These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 10629186

  • 21. Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.
    Sun N, Li D, Fonzi W, Li X, Zhang L, Calderone R.
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5931-9. PubMed ID: 24041896
    [Abstract] [Full Text] [Related]

  • 22. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
    Reis de Sá LF, Toledo FT, Gonçalves AC, Sousa BA, Dos Santos AA, Brasil PF, Duarte da Silva VA, Tessis AC, Ramos JA, Carvalho MA, Lamping E, Ferreira-Pereira A.
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Identification of promoter elements responsible for the regulation of MDR1 from Candida albicans, a major facilitator transporter involved in azole resistance.
    Rognon B, Kozovska Z, Coste AT, Pardini G, Sanglard D.
    Microbiology (Reading); 2006 Dec; 152(Pt 12):3701-3722. PubMed ID: 17159223
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
    Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA.
    Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
    [Abstract] [Full Text] [Related]

  • 26. Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1.
    Schubert S, Popp C, Rogers PD, Morschhäuser J.
    Eukaryot Cell; 2011 Aug; 10(8):1110-21. PubMed ID: 21685320
    [Abstract] [Full Text] [Related]

  • 27. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
    Maebashi K, Niimi M, Kudoh M, Fischer FJ, Makimura K, Niimi K, Piper RJ, Uchida K, Arisawa M, Cannon RD, Yamaguchi H.
    J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
    [Abstract] [Full Text] [Related]

  • 28. Competitive Fitness of Fluconazole-Resistant Clinical Candida albicans Strains.
    Popp C, Hampe IAI, Hertlein T, Ohlsen K, Rogers PD, Morschhäuser J.
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461316
    [Abstract] [Full Text] [Related]

  • 29. Molecular aspects of fluconazole resistance development in Candida albicans.
    Franz R, Ruhnke M, Morschhäuser J.
    Mycoses; 1999 Jul; 42(7-8):453-8. PubMed ID: 10546486
    [Abstract] [Full Text] [Related]

  • 30. Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance.
    Liu Z, Myers LC.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807921
    [Abstract] [Full Text] [Related]

  • 31. Rifampicin induces MDR1 expression in Candida albicans.
    Vogel M, Hartmann T, Köberle M, Treiber M, Autenrieth IB, Schumacher UK.
    J Antimicrob Chemother; 2008 Mar; 61(3):541-7. PubMed ID: 18238892
    [Abstract] [Full Text] [Related]

  • 32. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
    Looi CY, D' Silva EC, Seow HF, Rosli R, Ng KP, Chong PP.
    FEMS Microbiol Lett; 2005 Aug 15; 249(2):283-9. PubMed ID: 16006060
    [Abstract] [Full Text] [Related]

  • 33. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
    Jin L, Cao Z, Wang Q, Wang Y, Wang X, Chen H, Wang H.
    BMC Infect Dis; 2018 Apr 10; 18(1):162. PubMed ID: 29631565
    [Abstract] [Full Text] [Related]

  • 34. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J.
    Antimicrob Agents Chemother; 2001 Dec 10; 45(12):3416-21. PubMed ID: 11709317
    [Abstract] [Full Text] [Related]

  • 35. Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans.
    Flowers SA, Barker KS, Berkow EL, Toner G, Chadwick SG, Gygax SE, Morschhäuser J, Rogers PD.
    Eukaryot Cell; 2012 Oct 10; 11(10):1289-99. PubMed ID: 22923048
    [Abstract] [Full Text] [Related]

  • 36. Transcriptional analyses of antifungal drug resistance in Candida albicans.
    Lyons CN, White TC.
    Antimicrob Agents Chemother; 2000 Sep 10; 44(9):2296-303. PubMed ID: 10952571
    [Abstract] [Full Text] [Related]

  • 37. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole.
    Calabrese D, Bille J, Sanglard D.
    Microbiology (Reading); 2000 Nov 10; 146 ( Pt 11)():2743-2754. PubMed ID: 11065353
    [Abstract] [Full Text] [Related]

  • 38. Isogenic strain construction and gene targeting in Candida dubliniensis.
    Staib P, Moran GP, Sullivan DJ, Coleman DC, Morschhäuser J.
    J Bacteriol; 2001 May 10; 183(9):2859-65. PubMed ID: 11292806
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
    Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF.
    Antimicrob Agents Chemother; 2001 Oct 10; 45(10):2676-84. PubMed ID: 11557454
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.